Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species.
Microb Biotechnol
; 15(2): 482-498, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-33955652
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Saccharomyces cerevisiae Proteins
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Microb Biotechnol
Year:
2022
Document type:
Article
Affiliation country:
China